Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection
- 1 June 2006
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 44 (6) , 1026-1032
- https://doi.org/10.1016/j.jhep.2006.02.009
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infectionsJournal of Viral Hepatitis, 2004
- The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patientsJournal of Hepatology, 2004
- Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United StatesJournal of Hepatology, 2004
- Hepatic Steatosis in Hepatitis C Virus Genotype 3 Infection: Does It Correlate with Body Mass Index, Fibrosis, and HCV Risk Factors?Digestive Diseases and Sciences, 2004
- Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndromeAmerican Journal of Gastroenterology, 2003
- Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsiesGut, 2003
- Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patientsJournal of Hepatology, 2002
- Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic responseHepatology, 2002
- Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcoholHepatology, 2002
- Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and SteatosisHepatology, 1999